Overview

Duloxetine vs. Active Comparator in the Treatment of Patients With Depression

Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
How duloxetine compares to a medication currently available for the treatment of patients diagnosed with depression
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Duloxetine Hydrochloride
Venlafaxine Hydrochloride